Epoprostenol is a synthetic prostaglandin I2 analogue that acts as a potent vasodilator to treat pulmonary arterial hypertension and enhance exercise capacity. Ensuring the safety and efficacy of this… Read more
![Chemical structure of 5-((2R,3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)hexahydro-2H-2,5-epoxycyclopenta[b]furan-2-yl)pentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F91284-06-9-5-2R3aR4R5R6aS-4-SE-3-Hydroxyoct-1-en-1-ylhexahydro-2H-25-epoxycyclopentabfuran-2-ylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of 5-((3aS,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[b]furan-2-yl)pentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F65870-86-2-5-3aS4R5R6aS-5-Hydroxy-4-SE-3-hydroxyoct-1-en-1-yl-3a566a-tetrahydro-4H-cyclopentabfuran-2-ylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of 5-((3aS,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[b]furan-2-yl)pentanoic acid, sodium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F68979-98-6-5-3aS4R5R6aS-5-Hydroxy-4-SE-3-hydroxyoct-1-en-1-yl-3a566a-tetrahydro-4H-cyclopentabfuran-2-ylpentanoic-acid-sodium-Salt.png&w=3840&q=75)




![Chemical structure of Epoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclop (1237611)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F58962-34-8-Epoprostenol-Related-Compound-A-7-1R2R3R5S-35-Dihydroxy-2-SE-3-hydroxyoct-1-enylcyclop-1237611.png&w=3840&q=75)
Epoprostenol is a synthetic prostaglandin I2 analogue that acts as a potent vasodilator to treat pulmonary arterial hypertension and enhance exercise capacity. Ensuring the safety and efficacy of this pharmaceutical requires rigorous analysis, which is supported by a comprehensive range of Epoprostenol reference standards. Laboratories utilize these high-quality materials, including process-related impurities, degradation products like 6-ketoprostaglandin F1α, and various stereoisomers, to perform accurate impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for quantifying trace levels of the drug in complex matrices during bioanalytical studies. By maintaining access to these specialized compounds, pharmaceutical scientists can ensure precise quality control and regulatory compliance throughout the lifecycle of the active pharmaceutical ingredient.